Published on Web 07/22/2006
Total Synthesis of (-)- and ent-(+)-Vindoline and Related
Alkaloids
Hayato Ishikawa, Gregory I. Elliott, Juraj Velcicky,
Younggi Choi, and Dale L. Boger*
Contribution from the Department of Chemistry and The Skaggs Institute for Chemical Biology,
The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037
Received February 21, 2006; E-mail: boger@scripps.edu
Abstract: A concise 11-step total synthesis of (-)- and ent-(+)-vindoline (3) is detailed based on a unique
tandem intramolecular [4 + 2]/[3 + 2] cycloaddition cascade of a 1,3,4-oxadiazole inspired by the natural
product structure, in which three rings and four C-C bonds are formed central to the characteristic
pentacyclic ring system setting all six stereocenters and introducing essentially all the functionality found
in the natural product in a single step. As key elements of the scope and stereochemical features of the
reaction were defined, a series of related natural products of increasing complexity were prepared by total
synthesis including both enantiomers of minovine (4), 4-desacetoxy-6,7-dihydrovindorosine (5), 4-des-
acetoxyvindorosine (6), and vindorosine (7) as well as N-methylaspidospermidine (11). Subsequent
extensions of the approach provided both enantiomers of 6,7-dihydrovindoline (8), 4-desacetoxyvindoline
(9), and 4-desacetoxy-6,7-dihydrovindoline (10).
Introduction
Herein, we provide full details of the development of an
unusually concise total synthesis of (-)- and ent-(+)-vindoline8-10
(3) in which the full pentacyclic skeleton complete with all
substituents and all six stereocenters is created in a single step
enlisting a tandem intramolecular [4 + 2]/[3 + 2] cycloaddition
cascade of a 1,3,4-oxadiazole that was inspired by the natural
product structures.8 As detailed in ref 11, we extended the scope
of an intermolecular 1,3,4-oxadiazole [4 + 2]/[3 + 2] reaction
cascade beyond that which provides symmetrical 2:1 cycload-
ducts by implementing the reaction in an intramolecular
fashion.12 The reaction cascade is initiated by a [4 + 2]
cycloaddition reaction of the 1,3,4-oxadiazole with a tethered
dienophile that, for 3, entailed the use of an electron-
Vinblastine (1) and vincristine (2) constitute the most widely
recognized members of a class of bisindole alkaloids as a result
of their clinical use as antitumor drugs (Figure 1).1 Originally
isolated in trace quantities from Cantharanthus roseus (L.) G.
Don,2 their biological properties were among the first to be
shown to arise from inhibition of microtubule formation and
mitosis that today is still regarded as one of the more successful
drug targets for the treatment of cancer.3 In addition to being
among the first natural products whose structures were deter-
mined by X-ray, they were also among the first for which X-ray
of a heavy atom derivative was used to establish their absolute
configuration.4 Vindoline (3),4,5 a major alkaloid of Cantha-
ranthus roseus, constitutes the most complex half of vinblastine
and serves as both a biosynthetic2 and synthetic6 precursor to
the natural product.7
(8) Choi, Y.; Ishikawa, H.; Velcicky, J.; Elliott, G. I.; Miller, M. M.; Boger,
D. L. Org. Lett. 2005, 7, 4539.
(9) Racemic total syntheses: (a) Ando, M.; Bu¨chi, G.; Ohnuma, T. J. Am.
Chem. Soc. 1975, 97, 6880. (b) Kutney, J. P.; Bunzli-Trepp, U.; Chan, K.
K.; De Souza, J. P.; Fujise, Y.; Honda, T.; Katsube, J.; Klein, F. K.;
Leutwiler, A.; Morehead, S.; Rohr, M.; Worth, B. R. J. Am. Chem. Soc.
1978, 100, 4220. (c) Andriamialisoa, R. Z.; Langlois, N.; Langlois, Y. J.
Org. Chem. 1985, 50, 961. Formal racemic total syntheses: (d) Ban, Y.;
Sekine, Y.; Oishi, T. Tetrahedron Lett. 1978, 2, 151. (e) Takano, S.;
Shishido, K.; Sato, M.; Yuta, K.; Ogasawara, K. J. Chem. Soc., Chem.
Commun. 1978, 943. Takano, S.; Shishido, K.; Matsuzaka, J.; Sato, M.;
Ogasawara, K. Heterocycles 1979, 13, 307. (f) Danieli, B.; Lesma, G.;
Palmisano, G.; Riva, R. J. Chem. Soc., Chem. Commun. 1984, 909. Danieli,
B.; Lesma, G.; Palmisano, G.; Riva, R. J. Chem. Soc., Perkin Trans. 1
1987, 155. (g) Zhou, S.; Bommeziijn, S.; Murphy, J. A. Org. Lett. 2002,
4, 443.
(1) Neuss, N.; Neuss, M. N. In The Alkaloids; Brossi, A., Suffness, M., Eds.;
Academic: San Diego, 1990; Vol. 37, p 229.
(2) (a) Noble, R. L.; Beer, C. T.; Cutts, J. H. Ann. N.Y. Acad. Sci. 1958, 76,
882. (b) Noble, R. L. Lloydia 1964, 27, 280. (c) Svoboda, G. H.; Nuess,
N.; Gorman, M. J. Am. Pharm. Assoc. Sci. Ed. 1959, 48, 659.
(3) (a) Owellen, R. I.; Hartke, C. A.; Dickerson, R. M.; Haines, F. O. Cancer
Res. 1976, 36, 1499. (b) Pearce, H. L. In The Alkaloids; Brossi, A., Suffness,
M., Eds.; Academic: San Diego, 1990; Vol. 37, p 145.
(4) Moncrief, J. W.; Lipscomb, W. N. J. Am. Chem. Soc. 1965, 87, 4963.
(5) Gorman, M.; Neuss, N.; Biemann, K. J. Am. Chem. Soc. 1962, 84, 1058.
(6) (a) Mangeney, P.; Andriamialisoa, R. Z.; Langlois, N.; Langlois, Y.; Potier,
P. J. Am. Chem. Soc. 1979, 101, 2243. (b) Kutney, J. P.; Choi, L. S. L.;
Nakano, J.; Tsukamoto, H.; McHugh, M.; Boulet, C. A. Heterocycles 1988,
27, 1845. (c) Kuehne, M. E.; Matson, P. A.; Bornmann, W. G. J. Org.
Chem. 1991, 56, 513. (d) Magnus, P.; Mendoza, J. S.; Stamford, A.; Ladlow,
M.; Willis, P. J. Am. Chem. Soc. 1992, 114, 10232. (e) Yokoshima, S.;
Ueda, T.; Kobayashi, S.; Sato, A.; Kuboyama, T.; Tokuyama, H.;
Fukuyama, T. J. Am. Chem. Soc. 2002, 124, 2137. Kuboyama, T.;
Yokoshima, S.; Tokuyama, H.; Fukuyama, T. Proc. Natl. Acad. Sci. U.S.A.
2004, 101, 11966.
(10) Enantioselective total syntheses: (a) Feldman, P. L.; Rapoport, H. J. Am.
Chem. Soc. 1987, 109, 1603. (b) Kuehne, M. E.; Podhorez, D. E.; Mulamba,
T.; Bornmann, W. G. J. Org. Chem. 1987, 52, 347. (c) Kobayashi, S.;
Ueda, T.; Fukuyama, T. Synlett 2000, 883. Formal enantioselective total
syntheses: (d) Cardwell, K.; Hewitt, B.; Ladlow, M.; Magnus, P. J. Am.
Chem. Soc. 1988, 110, 2242.
(11) Elliott, G. I.; Fuchs, J. R.; Blagg, B. S. J.; Ishikawa, H.; Yuan, Z.-Q.; Tao,
H.; Boger, D. L. J. Am. Chem. Soc. 2006, 128, 10589.
(12) (a) Wilkie, G. D.; Elliott, G. I.; Blagg, B. S. J.; Wolkenberg, S. E.; Soenen,
D. R.; Miller, M. M.; Pollack, S.; Boger, D. L. J. Am. Chem. Soc. 2002,
124, 11292.
(7) Review: Kuehne, M. E.; Marko, I. In The Alkaloids; Brossi, A., Suffness,
M., Eds.; Academic: San Diego, 1990; Vol. 37, p 77.
9
10596
J. AM. CHEM. SOC. 2006, 128, 10596-10612
10.1021/ja061256t CCC: $33.50 © 2006 American Chemical Society